Wells Fargo & Company »

Lyell Immunopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $137k 61k 2.23
2023-12-31 $104k 53k 1.94
2023-09-30 $177k 120k 1.47
2023-06-30 $384k 121k 3.18
2022-09-30 $12k 1.6k 7.78
2022-06-30 $8.0k 1.2k 6.62
2022-03-31 $46k 9.1k 5.07
2021-12-31 $0 48 0.00
2021-09-30 $2.0k 129 15.50